Author [ Title(Desc)] Type Year
Filters: Author is Gulzar, Shah-E-Jahan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Asokan MS, Joan RFlorina, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V et al..  2024.  Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.. Lancet Reg Health Southeast Asia. 22:100361.
N
Bhatt T, Dam B, Khedkar SUday, Lall S, Pandey S, Kataria S, Ajnabi J, Gulzar S-E-J, Dias PM, Waskar M et al..  2023.  Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption.. Front Immunol. 14:1255478.
S
Prabhakara C, Godbole R, Sil P, Jahnavi S, Gulzar S-E-J, van Zanten TS, Sheth D, Subhash N, Chandra A, Shivaraj A et al..  2021.  Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.. PLoS Pathog. 17(7):e1009706.